Loading...
Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives
Coronavirus SARS-CoV2 has emerged as one of the greatest infectious disease health challenges in a century. Patients with multiple sclerosis (MS) have a particular vulnerability to infections through their use of immunosuppressive disease-modifying therapies (DMTs). Specific DMTs pose particular ris...
Saved in:
| Published in: | Neurotherapeutics |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer International Publishing
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7853164/ https://ncbi.nlm.nih.gov/pubmed/33533012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-021-01008-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|